Hemanext Gains New Funding for Blood-Storage Technology – The Wall Street Journal

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit https://www.djreprints.com.
Hemanext Inc. has secured new venture-capital funding ahead of plans to seek U.S. regulatory authorization for a medical device designed to improve blood storage and help patients who depend heavily on donated blood.
Lexington, Mass.-based Hemanext has collected $15 million in new funding and has now raised a total of more than $100 million.
Copyright 2021 Dow Jones & Company, Inc. All Rights Reserved
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.